drugset / Trial / NCT04581772
A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a Phase 1 relative bioavailability study carried out in approximately 24 healthy male subjects and healthy female subjects of non childbearing potential to investigate the effects of formulation and food on the safety, tolerability, and pharmacokinetics (PK) of DNL343.
Timeline
- Start
- 2020-12-23
- Primary completion
- 2021-06-04
- Completion
- 2021-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EVETIFATOR | Small molecule | — | Oral |
Indications
No indication recorded.